Investors

ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing novel human immunomodulatory proteins. ImmunOs Therapeutics AG has a novel portfolio of candidates in preclinical development and is currently exploring strategic collaborations with leading global pharmaceutical companies.